Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 16583718)

1.

Cardiac valvulopathy associated with pergolide use.

Zadikoff C, Rochon P, Lang A.

Can J Neurol Sci. 2006 Feb;33(1):27-33. Review.

PMID:
16583718
2.

Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.

Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G.

Cardiovasc Ther. 2011 Dec;29(6):404-10. doi: 10.1111/j.1755-5922.2010.00169.x. Epub 2010 Jun 11.

PMID:
20553285
3.

[Cardiac valvulopathy and dopamine agonist].

Grandas F.

Neurologia. 2007 Dec;22(10):870-81. Review. Spanish.

PMID:
17671852
4.

Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.

Kenangil G, Ozekmekçi S, Koldas L, Sahin T, Erginöz E.

Clin Neurol Neurosurg. 2007 May;109(4):350-3. Epub 2007 Feb 20.

PMID:
17307289
5.

Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.

Corvol JC, Anzouan-Kacou JB, Fauveau E, Bonnet AM, Lebrun-Vignes B, Girault C, Agid Y, Lechat P, Isnard R, Lacomblez L.

Arch Neurol. 2007 Dec;64(12):1721-6. Review.

PMID:
18071034
6.

[Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations].

Corvol JC, Schüpbach M, Bonnet AM; Centre d'Investigation Clinique et Fédération des Maladies du Système Nerveux, Hôpital de la Pitié-Salpêtrière, Paris.

Rev Neurol (Paris). 2005 Jul;161(6-7):637-43. Review. French.

PMID:
16141947
7.

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.

Antonini A, Poewe W.

Lancet Neurol. 2007 Sep;6(9):826-9. Review.

PMID:
17706566
8.

Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.

Dewey RB 2nd, Reimold SC, O'Suilleabhain PE.

Arch Neurol. 2007 Mar;64(3):377-80.

PMID:
17353380
9.

Pergolide associated cardiac valvulopathy based on Ontario administrative data.

Zadikoff C, Duong-Hua M, Sykora K, Marras C, Lang A, Rochon P.

Can J Neurol Sci. 2008 May;35(2):173-8.

PMID:
18574930
10.

Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.

Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB Jr.

Neurology. 2004 Jul 27;63(2):301-4.

PMID:
15277624
11.

The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008.

Ooba N, Yamaguchi T, Kubota K.

Drug Saf. 2011 Apr 1;34(4):329-38. doi: 10.2165/11588230-000000000-00000.

PMID:
21417505
12.

Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.

Senol MG, Togrol RE.

Neurology. 2007 Jul 3;69(1):117; author reply 117-8. No abstract available.

PMID:
17606893
13.

Dopamine agonists and the risk of cardiac-valve regurgitation.

Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E.

N Engl J Med. 2007 Jan 4;356(1):29-38.

14.

Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study.

Peralta C, Wolf E, Alber H, Seppi K, Müller S, Bösch S, Wenning GK, Pachinger O, Poewe W.

Mov Disord. 2006 Aug;21(8):1109-13.

PMID:
16622856
15.

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.

Van Camp G, Flamez A, Cosyns B, Weytjens C, Muyldermans L, Van Zandijcke M, De Sutter J, Santens P, Decoodt P, Moerman C, Schoors D.

Lancet. 2004 Apr 10;363(9416):1179-83.

PMID:
15081648
16.

Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide.

Van Camp G, Flamez A, Cosyns B, Goldstein J, Perdaens C, Schoors D.

Neurology. 2003 Sep 23;61(6):859-61.

PMID:
14504342
17.

Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide.

Růzicka E, Línková H, Penicka M, Ulmanová O, Nováková L, Roth J.

J Neurol. 2007 Nov;254(11):1575-8. Epub 2007 Aug 24.

PMID:
17712588
18.

[Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease].

Muraki M, Mikami T, Kitaguchi M, Sugawara T, Isonishi K, Kaneko S, Kashiwaba T, Moriwaka F, Yamada S, Onozuka H, Tsutsui H.

J Cardiol. 2005 Dec;46(6):221-7. Japanese.

PMID:
16389741
19.

Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.

Pullan PT.

Intern Med J. 2009 Apr;39(4):213-5. doi: 10.1111/j.1445-5994.2009.01916.x. No abstract available.

PMID:
19402858
20.

Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.

Simonis G, Fuhrmann JT, Strasser RH.

Mov Disord. 2007 Oct 15;22(13):1936-42.

PMID:
17659636
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk